Icon launches new FSP strategy

Wednesday, November 7, 2012 10:03 AM

Global CRO Icon has launched a new functional resourcing strategy delivered by a dedicated division, DOCS, consolidating functional service provision (FSP) and resourcing services into one division.

DOCS has been a provider of resourcing services to the global biopharmaceutical and medical device industry for over 15 years. To meet the growing demand for FSP solutions, DOCS has developed the FSP Delivery Platform. This combines DOCS’ global resourcing engine with the processes, quality oversight, systems and training and governance structures to drive productivity through flexible FSP models. The DOCS FSP Delivery Platform also leverages Icon’s therapeutic, geographic and functional expertise to ensure greater efficiencies across customer programs.

“Functional resourcing and FSP continue to grow in popularity as sponsors look for innovative outsourcing strategies that enable them to gain efficiencies and accelerate the development of their pipelines,” said Colin Stanley, president, DOCS. “DOCS’ core competency is providing highly talented teams with skills and experience that are aligned with the needs of our clients and which seamlessly integrate with their business. Our new FSP Delivery Platform builds on this competency and also allows clients to benefit from the breadth and depth of capabilities and expertise from the wider Icon organization.”

The DOCS FSP business will be led by Barry Balfe, vice president of global program management, who has 12 years of clinical research experience and has held leadership positions in both operations and business development for DOCS.

DOCS specializes in functional service provision, contract placement, permanent placement and executive search, and has a global resourcing network and operational infrastructure across 82 locations in 40 countries. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs